Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days

NEXT STORY
Iterum Therapeutics plc Announces $10 Million Bought Deal Public Offering of Ordinary Shares
PREV STORY
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Correction to company release dated January 26, 2018 – Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares – number of shares

FIT Biotech Oy Company release January 29, 2018 at 11:35 AM EET Correction to ...

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Announces In Vivo Study to Evaluate the Effects of CPI-613® (Devimistat) in Combination with Azacitidine and Venetoclax on Acute Myeloid Leukemia Models

author_avatar
NASDAQ Market News

Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

author_avatar
NASDAQ Market News